Oppenheimer's One Buy Vs. One Sell Idea From Each SMID Sector
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Viking Therapeutics Insider Sold Shares Worth $1,272,000, According to a Recent SEC Filing
Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $120
Viking Therapeutics Options Spot-On: On October 25th, 90,685 Contracts Were Traded, With 218.76K Open Interest
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $95 to $125
